1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with suplatast tosilate in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (suplatast tosilate) | Trials (suplatast tosilate) | Recent Studies (post-2010) (suplatast tosilate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 149 | 19 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, Y; Nagata, M; Sakamoto, Y; Yamamoto, H | 1 |
| Agrawal, DK; Suwaki, T; Townley, RG | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and suplatast tosilate
| Article | Year |
|---|---|
[Inhibitory effect of suplatast tosilate on eosinophil migration].
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Movement; Eosinophils; Histamine Antagonists; Humans; In Vitro Techniques; Interleukin-6; Platelet Activating Factor; Sulfonium Compounds | 2000 |
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Adhesion; Cells, Cultured; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Endothelium, Vascular; Eosinophils; Gene Expression Regulation; Humans; Integrin alpha4beta1; Integrins; Interleukin-4; Platelet Activating Factor; Pulmonary Eosinophilia; Receptors, Lymphocyte Homing; Respiratory Hypersensitivity; Sulfonium Compounds; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2001 |